Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000948255 | SCV000718774 | benign | not provided | 2019-07-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 17216251, 14582039) |
Labcorp Genetics |
RCV000948255 | SCV001094455 | benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000948255 | SCV001143220 | benign | not provided | 2018-11-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001138281 | SCV001298322 | likely benign | Alport syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Ce |
RCV000948255 | SCV001746408 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | COL4A3: BP4, BP7 |
Breakthrough Genomics, |
RCV000948255 | SCV005259004 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003891830 | SCV000302066 | benign | COL4A3-related disorder | 2021-05-20 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000252105 | SCV001952817 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000948255 | SCV001974189 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000948255 | SCV001977927 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001138281 | SCV002076374 | benign | Alport syndrome | 2019-12-03 | no assertion criteria provided | clinical testing |